184 related articles for article (PubMed ID: 29225479)
1. Density of CD8+ lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancer.
Xiao B; Peng J; Zhang R; Xu J; Wang Y; Fang Y; Lin J; Pan Z; Wu X
Cancer Manag Res; 2017; 9():701-708. PubMed ID: 29225479
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of combining the CD8 + lymphocyte density and the circulating lymphocyte ratio in circumferential resection margin biopsy in rectal cancer.
Wu B; Zhao S; Sheng Y; Ren L; Song G
Medicine (Baltimore); 2018 Aug; 97(34):e11972. PubMed ID: 30142826
[TBL] [Abstract][Full Text] [Related]
3. Tumor infiltrating lymphocytes and neutrophil-to-lymphocyte ratio in relation to pathological complete remission to neoadjuvant therapy and prognosis in triple negative breast cancer.
Zhao M; Xing H; He J; Wang X; Liu Y
Pathol Res Pract; 2023 Aug; 248():154687. PubMed ID: 37478522
[TBL] [Abstract][Full Text] [Related]
4. Local environment in biopsy better predict the pathological response to neoadjuvant chemoradiotherapy in rectal cancer.
Huang Y; Lou XY; Zhu YX; Wang YC; Zhang L; Liu HL; Wang C; Zhan HM; Cheng ZQ; Tan WY; Wang L; Fan XJ
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30867256
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer.
Teng F; Meng X; Kong L; Mu D; Zhu H; Liu S; Zhang J; Yu J
Transl Res; 2015 Dec; 166(6):721-732.e1. PubMed ID: 26209749
[TBL] [Abstract][Full Text] [Related]
6. Systemic Inflammatory Markers Combined with Tumor-Infiltrating Lymphocyte Density for the Improved Prediction of Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.
Sawada R; Akiyoshi T; Kitagawa Y; Hiyoshi Y; Mukai T; Nagasaki T; Yamaguchi T; Konishi T; Yamamoto N; Ueno M; Fukunaga Y
Ann Surg Oncol; 2021 Oct; 28(11):6189-6198. PubMed ID: 33876358
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancer.
Kusama H; Kittaka N; Soma A; Taniguchi A; Kanaoka H; Nakajima S; Oyama Y; Seto Y; Okuno J; Watanabe N; Matsui S; Nishio M; Fujisawa F; Honma K; Tamaki Y; Nakayama T
Breast Cancer; 2023 Nov; 30(6):1085-1093. PubMed ID: 37782377
[TBL] [Abstract][Full Text] [Related]
8. Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer.
Matsutani S; Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Hirakawa K; Ohira M
Cancer Sci; 2018 Apr; 109(4):966-979. PubMed ID: 29464828
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil to Lymphocyte Ratio: A Predictive Marker for Treatment Outcomes in Patients With Rectal Cancer Who Underwent Neoadjuvant Chemoradiation Followed by Surgery.
Jeon BH; Shin US; Moon SM; Choi JI; Kim MS; Kim KH; Sung SJ
Ann Coloproctol; 2019 Apr; 35(2):100-106. PubMed ID: 31113175
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil-lymphocyte ratio reflects tumour-infiltrating lymphocytes and tumour-associated macrophages and independently predicts poor outcome in breast cancers with neoadjuvant chemotherapy.
Li JJX; Ni SYB; Tsang JYS; Chan WY; Hung RKW; Lui JWH; Ng SWY; Shum LK; Tang YF; Tse GM
Histopathology; 2024 Apr; 84(5):810-821. PubMed ID: 38192219
[TBL] [Abstract][Full Text] [Related]
11. CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer.
Shinto E; Hase K; Hashiguchi Y; Sekizawa A; Ueno H; Shikina A; Kajiwara Y; Kobayashi H; Ishiguro M; Yamamoto J
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S414-21. PubMed ID: 24566864
[TBL] [Abstract][Full Text] [Related]
12. Platelet-to-Lymphocyte Ratio Is Associated With Favorable Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Study on 120 Patients.
Lusho S; Durando X; Mouret-Reynier MA; Kossai M; Lacrampe N; Molnar I; Penault-Llorca F; Radosevic-Robin N; Abrial C
Front Oncol; 2021; 11():678315. PubMed ID: 34367964
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment blood biomarkers combined with magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Shi X; Zhao M; Shi B; Chen G; Yao H; Chen J; Wan D; Gu W; He S
Front Oncol; 2022; 12():916840. PubMed ID: 36016621
[TBL] [Abstract][Full Text] [Related]
14. Utility of neutrophil-to-lymphocyte ratio as an indicator of tumor immune status in non-small cell lung cancer.
Iwata K; Suzawa K; Hashimoto K; Tanaka S; Shien K; Miyoshi K; Yamamoto H; Okazaki M; Sugimoto S; Toyooka S
Jpn J Clin Oncol; 2024 May; ():. PubMed ID: 38704243
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the density of tumor-infiltrating lymphocytes in colorectal cancer liver metastases.
Wang E; Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Okazaki Y; Kashiwagi S; Tanaka H; Maeda K
Oncol Lett; 2021 Dec; 22(6):837. PubMed ID: 34712361
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of tumor-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio in patients with stage III colon cancer who underwent surgery followed by FOLFOX chemotherapy.
Cha YJ; Park EJ; Baik SH; Lee KY; Kang J
Sci Rep; 2019 Aug; 9(1):11617. PubMed ID: 31406179
[TBL] [Abstract][Full Text] [Related]
17. Predicting Neoadjuvant Chemoradiotherapy Response in Locally Advanced Rectal Cancer Using Tumor-Infiltrating Lymphocytes Density.
Xu Y; Lou X; Liang Y; Zhang S; Yang S; Chen Q; Xu Z; Zhao M; Li Z; Zhao K; Liu Z
J Inflamm Res; 2021; 14():5891-5899. PubMed ID: 34785927
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy.
Karaca M; Salim E; Alemdar MS; Deniz Karaca Ö; Arıcı MÖ
Med Sci Monit; 2024 Mar; 30():e943750. PubMed ID: 38544312
[TBL] [Abstract][Full Text] [Related]
19. Systemic inflammatory indices predict tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Lai S; Huang L; Luo S; Liu Z; Dong J; Wang L; Kang L
Oncol Lett; 2020 Sep; 20(3):2763-2770. PubMed ID: 32782593
[TBL] [Abstract][Full Text] [Related]
20. The predictive value of peripheral blood cells and lymphocyte subsets in oesophageal squamous cell cancer patients with neoadjuvant chemoradiotherapy.
Zhou J; Lin HP; Xu X; Wang XH; Rong L; Zhang Y; Shen L; Xu L; Qin WT; Ye Q; Ma XM; Bai YR
Front Immunol; 2022; 13():1041126. PubMed ID: 36451825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
